BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31274561)

  • 1. Giant Melanotic Malignant Peripheral Nerve Sheath Tumor in the Pelvis: Contrast-Enhanced CT and 18F-FDG PET/CT Finding.
    Liu E; Sun T; Liu C; Wang S; Wang S
    Clin Nucl Med; 2019 Nov; 44(11):895-897. PubMed ID: 31274561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant Peripheral Nerve Sheath Tumor With Bilateral Adrenal Metastases: Role of 18F-FDG PET/CT in Response Assessment to Tyrosine Kinase Inhibitor and Liposomal Doxorubicin.
    Tripathy S; Passah A; Singhal A; Prashanth A; Kumar R
    Clin Nucl Med; 2019 Jun; 44(6):494-495. PubMed ID: 30889004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of 18F-FDG PET/computed tomography in prognostication and management of malignant peripheral nerve sheath tumors.
    Yadav D; Shamim SA; Rastogi S; Upadhyay DMR; Pandey AK; Kumar R
    Nucl Med Commun; 2020 Sep; 41(9):924-932. PubMed ID: 32796481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional imaging of RAS pathway targeting in malignant peripheral nerve sheath tumor cells and xenografts.
    Butler E; Schwettmann B; Geboers S; Hao G; Kim J; Nham K; Sun X; Laetsch TW; Xu L; Williams NS; Skapek SX
    Pediatr Blood Cancer; 2020 Dec; 67(12):e28639. PubMed ID: 32975370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac Malignant Peripheral Nerve Sheath Tumor Accessed By
    Soares Brandão SC; Dompieri LT; Tonini RC; Grativvol PS; Gama JD; Calado EB; Monteiro Pedroti FC
    Can J Cardiol; 2020 Jun; 36(6):967.e17-967.e19. PubMed ID: 32389686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solitary Malignant Peripheral Nerve Sheath Tumor of Lumbar Vertebra Mimicking Metastatic Malignancy.
    Guo Z; Liu W; Dong Z; Yang L; Xie P
    Clin Nucl Med; 2023 May; 48(5):435-436. PubMed ID: 36800240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiologic uptake of 18F-FDG in transposed ovaries may mimic metastasis on 18F-FDG PET/CT imaging.
    Davidson T; Komisar O; Korach J; Felder S; Apter S; Ben-Haim S; Perri T
    Nucl Med Commun; 2018 Feb; 39(2):171-178. PubMed ID: 29215392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pelvic Leiomyosarcoma With Splenic Metastasis and Response Assessment by 18F-FDG PET/CT.
    Yadav D; Kumar R; Rastogi S; Shamim SA
    Clin Nucl Med; 2020 Jul; 45(7):547-548. PubMed ID: 32404703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant Peripheral Nerve Sheath Tumor Arising From Transplanted Kidney Assessed by 18F-FDG PET/CT.
    Feng H; Tu N; Bu L
    Clin Nucl Med; 2020 Nov; 45(11):905-907. PubMed ID: 32969901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of additional 18F-FDG PET/CT imaging using a vaginal catheter in patients with paravaginal malignant lesions.
    Ucak Semirgin S; Basoglu T; Atmaca Saglik B; Sahin M; Yapici O
    Nucl Med Commun; 2016 Dec; 37(12):1260-1266. PubMed ID: 27466019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-body staging of female patients with recurrent pelvic malignancies: Ultra-fast 18F-FDG PET/MRI compared to 18F-FDG PET/CT and CT.
    Kirchner J; Sawicki LM; Suntharalingam S; Grueneisen J; Ruhlmann V; Aktas B; Deuschl C; Herrmann K; Antoch G; Forsting M; Umutlu L
    PLoS One; 2017; 12(2):e0172553. PubMed ID: 28225831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of 18F-FDG PET/CT with retrograde filling of the urinary bladder in patients with suspected pelvic malignancies.
    Vicente AM; Castrejón AS; Muñoz AP; Woll PP; García AN
    J Nucl Med Technol; 2010 Sep; 38(3):128-37. PubMed ID: 20807854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic performance of 18F-FDG PET/contrast-enhanced CT versus contrast-enhanced CT alone for post-treatment detection of ovarian malignancy.
    Tawakol A; Abdelhafez YG; Osama A; Hamada E; El Refaei S
    Nucl Med Commun; 2016 May; 37(5):453-60. PubMed ID: 26745811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of cavernous hemangioma in which malignancy was preoperatively excluded by FDG-PET.
    Higashiyama S; Kawabe J; Hayashi T; Kurooka H; Oe A; Kotani J; Kawamura E; Shiomi S
    Ann Nucl Med; 2008 May; 22(4):327-30. PubMed ID: 18535885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is integrated 18F-FDG PET/MRI superior to 18F-FDG PET/CT in the differentiation of incidental tracer uptake in the head and neck area?
    Schaarschmidt BM; Gomez B; Buchbender C; Grueneisen J; Nensa F; Sawicki LM; Ruhlmann V; Wetter A; Antoch G; Heusch P
    Diagn Interv Radiol; 2017; 23(2):127-132. PubMed ID: 28089955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CT, MRI, and
    Kim HY; Hwang JY; Kim HJ; Kim YK; Cha J; Park GM; Kim ST
    Acta Radiol; 2017 Oct; 58(10):1222-1230. PubMed ID: 28068826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retroperitoneal Recurrence of Melanotic Schwannoma on 18F-FDG PET/CT.
    OuYang X; Zheng L; Zhang X
    Clin Nucl Med; 2021 Dec; 46(12):991-993. PubMed ID: 34560691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced CT and FDG PET/CT in primary malignant peripheral nerve sheath tumor of the uterine cervix.
    Dong A; Zuo C; Wang Y; Zhai Z; Xu M
    Clin Nucl Med; 2014 Sep; 39(9):825-7. PubMed ID: 24300355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Uptake on Preoperative Positron Emission Tomography/Computed Tomography in the Lymph Nodes of Patients with Primary Colorectal Cancer.
    Sasaki K; Kawasaki H; Sato M; Koyama K; Yoshimi F; Nagai H
    Dig Surg; 2017; 34(1):60-67. PubMed ID: 27454870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.